Shows
FUTUREPROOF.The Future of Meaningful Work (ft. authors Wes Adams and Tamara Myles)Send us a textJoin us in a compelling discussion with Wes Adams and Tamara Myles, seasoned advisers to global companies and authors of MEANINGFUL WORK: How to Ignite Passion and Performance in Every Employee. Dive into the science of positive psychology and discover how it can transform leadership and workplace cultures.What You’ll Learn:The Importance of Meaning: Explore why meaningful work is crucial for employee engagement and organizational success.Leadership Influence: Understand the significant impact leaders have on cultivating a sense of meaning an...2025-04-0828 min
Immigration Ain't EasyImmigration Ain't Easy Ep. 22: Myles Traphagen, Borderlands Program Coordinator for the Wildlands NetworkSend us a textMyles Traphagen is the ultimate champion for migrant rights: for insects, animals and humans. He is a recognized advocate for the conservation and protection of our ecology in the face of human-created devastation. Myles is consistently cited to and quoted by numerous media organizations when it comes to the negative impact of the border wall on the natural environment on the U.S./Mexico border. As the Borderlands Program Coordinator for the Wildlands Network, Myles is the foremost expert on the borderlands region with a focus on channeling collaborative efforts to maintain and...2025-01-061h 09
Pulp FrictionPF #99: Interview with the Vampire (feat. Myles)On-set feuds. Studios collapsing. Tragic celebrity deaths. Real-life vampirism. The story of how AMC’s Anne Rice’s Anne Rice’s Interview with the Vampire came to be is undoubtedly one of the most harrowing we’ve ever covered. But what about the end result? Myles says yay, Rocky says… fine. Persons of interest include Cher, Bryan Fuller, and #JaredLeto.Pulp Friction is available wherever pods are cast. Subscribe and share to support the show. Send riddles to pulpfrictioncast@gmail.com.Pulp Friction is a reader-supported publication. To receive new posts and support my work, cons...2024-08-281h 13
Offloaded - The Travel Industry PodcastMichael Gazal and Tania Myles: The 7 Habits of Highly Effective Travel Advisors (Part Two!)Part TWO! Listen to part one first!Michael Gazal and Tania Myles of TravelManagers Australia return for Part Two of a 2024 travel industry take on the famous book 'The 7 Habits of Highly Effective People' by Stephen R. Covey. Working daily with a network of 450+ travel advisors (or in their terminology Personal Travel Managers), Michael and Tania are brilliantly positioned to talk about the common qualities they're seeing in advisors that are successfully navigating the current landscape.But what does 'successful' or 'effective' even mean when people are now...2024-05-1149 min
Milkcrates & MicrophonesMilkcrates & Microphones S8 Ep13.( HOLIDAZE Special Ft OSCAR GOLDMAN)In this Season 8 Episode 13 of Milkcrates & Microphones, we bring you our annual Holidaze Special, accompanied by Milk&Mics alumni/close friend of the podcast—Oscar Goldman. Along with Oscar, we dive into a number of topics including the 1-year anniversary of the self-titled Oscar Goldman album, doing a show at his High School, performing with the Co-Defendants, new projects in the works, dream collaborations, favorite Christmas movies, the top Christmas villain, best fast food restaurants, Aesop Rock’s Integrate Tech Solutions, Sole, Myles Bullen, the 2pac murder, skateboarding, plus so much more. We also bring you your favorite Milk&Mics...2024-02-242h 36
340B InsightAnnual 340B Recertification Is Here!It’s that time of year again when your 340B hospital must go through the annual 340B recertification process. 340B Health’s vice president of pharmacy services Steven Miller joins us to discuss what 340B covered entities need to know about recertification and how to recertify without any errors. How the Recertification Process WorksSteve explains the step-by-step process for covered entities to confirm and validate the accuracy of their information and ensure they are still eligible for 340B. Eligibility Criteria for HospitalsSteve discusses the cr...2023-08-1419 min340B InsightHow to Pursue a Career in 340BCindy Williams has critical advice for anyone wanting to start a career in 340B and pharmacy. Cindy is the vice president and chief pharmacy officer at Riverside Health System in Virginia. In this episode, she walks us through her 340B professional journey over the last three decades, from her initial dreams of having a career in health care to a leadership position that also involves managing a 340B program. She gives advice on building key relationships and driving impactful change in the industry. Before the interview, we provide updates on a newly proposed federal rule on repayments to 340B...2023-07-3120 min340B InsightThe Biggest Trends in Specialty PharmacySpecialty pharmacy trends have evolved significantly in recent years and even in the past few months. In this episode, Tim Paine, a specialty pharmacy expert who now heads up EPU Healthcare Consulting, dives into specialty pharmacy and its connection to the 340B program. Building off his decades of experience in pharmaceuticals and pharmacy, Tim discusses the high costs of specialty drugs, the crucial role of 340B discounts, and the challenges hospitals face navigating this ecosystem. Before the interview, we update listeners on the latest development in the ongoing 340B contract pharmacy issue.Challenges for Hospitals in Managing...2023-07-1019 min340B InsightBest Practices for Managing 340B Pharmacy Supply340B hospitals must navigate the challenging world of pharmacy supply chain management, in which they must balance budget constraints while providing high-quality care to all their patients. In this episode, we explore best practices for how hospitals can manage the 340B pharmacy supply chain. Our guest is Ashley Covert, system director of pharmacy supply chain and contracting at Dartmouth Health. Before the interview, we give an update on two problematic bills approved by the House Energy and Commerce Committee that would have adverse effects on 340B hospitals if they were to become law.Pharmacy Supply C...2023-06-0520 min
Pulp FrictionPF #70: Harry Styles (feat. Myles)It’s Myles on Styles this week as Rocky (she/her) and Myles (they/he) break down the strange arc of perpetual heartthrob Harry Styles. What is it about his persona that invites such extreme fandom and such extreme criticism? Is he baiting, or has he done enough? Persons of interest include Nick Jonas, Katy Perry, and our dear policeman.Pulp Friction is available wherever pods are cast. Subscribe and share to support the show. Reach out to Rocky or pulpfrictioncast@gmail.com with any business inquiries.Pulp Friction is a reader-supported publication. To re...2023-05-121h 18340B InsightThe Data on 340B Contract Pharmacy RestrictionsA recent report from 340B Health includes data on how drug company restrictions on 340B hospital partnerships with community and specialty contract pharmacies have taken a toll on the health care safety net and the patients who rely on it. On this episode, we speak with the report’s author, 340B Health Vice President of Research and Policy Analytics Caroline Steinberg, to walk through the findings and discuss what they mean for 340B hospitals and their patients. Before the interview, we provide a news update on a federal appeals court case regarding a 340B non-discrimination law in Arkansas. 2023-05-0118 min340B InsightAdvancing Maternal Health Through 340B340B contributes vital resources toward the pursuit of health equity for historically underserved communities. As we recognize National Minority Health Month, we speak with Fatimah Muhammad, director of 340B pharmaceutical services and drug replacement at Saint Peter’s University Hospital in New Brunswick, N.J. Fatimah discusses how her hospital uses 340B to address maternal health disparities, including support for a birth center to improve maternal health outcomes. Before the interview, we provide news updates on new 340B legislation in Congress and changes to drug company contract pharmacy policies. Causes of Maternal Health Disparities Fatimah sha...2023-04-1720 min340B InsightA Hospital CEO’s Advice for 340B Professionals340B helps health systems and hospitals stretch their resources and provide more services to patients in need. This makes 340B important to a hospital or health system leadership team’s ability to plan how it will deliver care. In this episode, we speak with Matthew Perry, president and CEO of Genesis Healthcare System in Zanesville, Ohio. Matt shares his perspective about 340B and how 340B professionals can best engage with their hospital CEO. Prior to the interview, we share findings from a new 340B Health report about the effects of drug company 340B contract pharmacy restrictions on patient care. 2023-04-0319 min340B Insight340B Internal Audits340B compliance is a critical requirement for hospitals participating in the program, and one of the ways 340B hospitals maintain compliance is through conducting internal audits. For this episode, we speak with Tristan Greer, 340B program business manager at Catholic Health in Buffalo, N.Y. Tristan has significant experience conducting 340B internal audits at the health system, and she shares several best practices for a successful internal audit. Before the interview, we provide a news update on how drug manufacturers are pursuing legislative changes to 340B and some of the responses to that proposal. T...2023-03-2016 min340B InsightHow One State Protected 340BState policymakers have increased the attention they are paying to 340B. In this episode, we hear from 340B state advocacy expert Abby Reale. Abby is director of government and external affairs with Mountain Health Network in West Virginia. The state has been a leader in protecting 340B, and she shares how her health system worked with other hospitals and provider organizations to advocate for the first 340B non-discrimination law in the nation. Prior to the interview, we provide a news update about a drug company that is imposing the pharmaceutical industry’s most restrictive limits on 340B pricing. 2023-03-0620 min340B InsightMaking IT Work With 340BHealth information technology (IT) is intertwined with 340B operations and compliance. So how can hospitals and health systems manage IT while keeping 340B in mind? To find out, we hear from Robert Owens, director of pharmacy enterprise shared services at Atrium Health. Bob is a pharmacy health IT expert, and he shares how the technology intersects with 340B. He also shares insights to ensure strong 340B operations and compliance when undergoing an electronic health records (EHR) system conversion. Before the interview, we provide an update on two more drug companies restricting 340B discounts. IT's I...2023-02-2119 min340B InsightMaureen Testoni’s Outlook for 340B In 2023Several 340B developments have occurred in the first weeks of 2023, with many more expected to come this year. In this episode, we speak with 340B Health President and CEO Maureen Testoni about her outlook for 340B. Our discussion includes her analysis of the latest in the 340B contract pharmacy dispute, the 340B advocacy landscape at the federal and state levels, and Medicare issues affecting 340B.*Editor’s note: We spoke with Maureen prior to Bayer and EMD Serono announcing they will restrict 340B discounts. When these restrictions start in March, at least 21 companies will be...2023-02-0626 min340B InsightYour 340B Questions AnsweredWe often receive listener questions about 340B issues and developments that affect professionals in the 340B world. In this episode, we open the listener virtual mailbag and answer some of your questions with help from our 340B Health staff experts. Some of the questions we tackle include queries about mitigating 340B contract pharmacy restrictions, understanding 340B patient definition, analyzing current 340B hospital audit trends, and examining Medicare Advantage payment rates for 340B drugs. Mitigating Contract Pharmacy Restrictions In response to a listener's question, we discuss ways 340B hospitals can access program savings de...2023-01-2422 min340B InsightHome Infusion and 340B ConsiderationsProviding care beyond hospital walls is a growing trend for 340B hospitals. One service that health systems provide outside of the hospital setting is home infusion care. On our first episode of 2023, we are joined by David Klinger and Seth Gazes from Geisinger Health to hear how 340B hospitals can establish home infusion care and the 340B considerations they should keep in mind. Prior to the interview, we provide an update on the 19th drug company to restrict 340B discounts for drugs dispensed at community and specialty contract pharmacies. We also recap drug manufacturer 340B overcharge notices in 2022.2023-01-0920 min340B InsightEducating Your Hospital Colleagues About 340B340B professionals are not the only hospital staff who need to know about 340B. That is why it is important that 340B professionals educate their colleagues about the program and what it means for clinical care and patient care operations. For our final episode of the year, 340B professional Ryan Atherton joins us to share the strategies he has deployed to help his colleagues better understand 340B’s role in the patient care mission. Ryan formerly was the 340B program manager at Yakima Valley Memorial Hospital in Washington State. He improved understanding of 340B among the hospital’s staff, whic...2022-12-1915 min340B InsightWhat the Midterm Election Results Mean for 340BThe recent election results have implications for the future of U.S. health policy and the 340B program. Health policy experts Debbie Curtis and Rodney Whitlock join us this week to discuss how the new Congress will affect 340B and how individuals can best engage in educating and advocating for the program. Debbie and Rodney are vice presidents at McDermott + Consulting and previously were congressional staffers. Before the interview, we provide an update on the litigation process in the 340B contract pharmacy dispute, and we recap HRSA audit results of drug companies. What Divided G...2022-12-0520 min340B InsightManaging 340B in a Rural HospitalNov. 17 is National Rural Health Day, which is an opportunity to celebrate the importance of rural hospitals to patients living in remote communities. We are joined by Karen McCombs, 340B program manager for Wills Memorial Hospital in Georgia. Karen shares her tips for managing her critical access hospital’s 340B program in a compliant and efficient manner to support patient care initiatives. Before the interview, we provide updates on the 2023 Medicare payment rate for 340B drugs and on the status of 340B contract pharmacy litigation pending in federal appeals courts. Where Everyone Knows Your Nam...2022-11-1419 min340B InsightCongressman Henry Waxman Reflects on 30 Years of 340BOn Nov. 4, 1992, President George H.W. Bush signed the 340B drug pricing program into law. To celebrate 30 years of 340B, we speak on today’s episode with former Congressman Henry Waxman, who was one of the principal architects of the 340B program. Congressman Waxman served in Congress for 40 years from 1975-2015. During part of that time, he chaired the influential U.S. House Energy & Commerce Committee and U.S. House Government & Oversight Committee. Chairman Waxman shares why Congress created 340B, explains the need for a strong health care safety net, discusses 340B’s achievements, and re...2022-11-0422 min340B InsightMoving Patients from Emergency Care to Coordinated CareWhen Hennepin Medical Center saw that some of their patients were frequently visiting the emergency department for all their health care needs, they recognized how vital it was to find a better way to care for them. Our guest this week is Christene Jolowsky, senior director of pharmacy at Hennepin Healthcare. Christene shares how Hennepin has used 340B savings to operate a coordinated care clinic that meets the health and social needs of their patients. Prior to the interview, we provide news updates on the restoration of full Medicare payment rates for 340B drugs and details about another drug...2022-10-2420 min340B InsightA 30-Year Perspective on 340BAll this year we are reflecting on the approaching 30th anniversary of the 340B program and celebrating the patient care successes the program has enabled over the past three decades. This week, we are joined by Andrew Lowe, clinical director of pharmacy at Arrowhead Regional Medical Center in California. Arrowhead has participated in 340B since the first days that hospitals were eligible for the program. Andy has had a front-row seat the entire time to see the difference 340B has made in the lives of patients in need and the health care safety net’s ability to care for th...2022-10-1119 min340B InsightMaureen Testoni Analyzes Recent 340B DevelopmentsIt has been an eventful summer for 340B, and we are checking in this week with 340B Health President and CEO Maureen Testoni to hear her analysis on the top 340B developments. Maureen provides updates on issues that include the contract pharmacy dispute, Medicare payment cuts, and the new drug pricing law. She also shares a preview of what may occur in the fall. 340B Contract Pharmacy Dispute Continues The number of companies currently restricting 340B discounts has grown. Maureen discusses the impact of these unlawful restrictions on 340B hospitals and patient ca...2022-09-2624 min340B InsightHow to Manage Drug ShortagesDrug shortages occurring throughout the U.S. health system can lead to delays for patients receiving the medications they need. 340B hospitals face unique challenges with avoiding and managing drug shortages. We are joined by Cescilly Smith-Jenkins, 340B program director at Ascension Wisconsin, to find out how 340B hospitals can address shortage problems effectively. Why Drug Shortages HappenThere are several factors behind drug shortages. Cescilly explains how drug shortages are affected by other supply shortages, outlines drug shortage trends in the U.S., and notes which drugs are most prone to b...2022-09-1217 min340B InsightPharmacy Technician ShortagesPharmacy technicians play key roles in hospital 340B program operations, but pharmacy technician staffing shortages are occurring in hospitals throughout the nation. We’re joined by Dr. Tyffani Wingfield with the American Society of Health-System Pharmacists (ASHP) to discuss how the shortages are affecting hospitals, the pharmacy technician workforce, and 340B. Tyffani also shares potential solutions. Before the interview, we discuss recently enacted federal drug pricing legislation and the start of the annual 340B hospital recertification process. Factors Contributing to the Pharmacy Tech ShortagePharmacy technician vacancy rates are high. Tyffani shares res...2022-08-2920 min340B InsightAre You Ready for 340B Recertification?It’s that time of year again to make sure your health system or hospital has everything it needs for the 340B recertification period. 340B Health Vice President of Pharmacy Services Steven Miller returns to the podcast to discuss what is new this year for the recertification process, go over the recertification steps, and provide best practices to recertify without any errors. What’s New for Recertification Steve shares the dates that recertification will take place this year and two significant changes from recent years that hospitals need to know. ...2022-08-1523 min340B Insight340B Inventory ManagementInventory management is a major responsibility for many 340B professionals. Today, we’re joined by Melissa Antonopoulos, senior 340B internal auditor at Memorial Healthcare System, to learn more. She discusses the intersection of 340B and inventory management and goes over practices for ensuring hospitals and their patients have the medications they need. In our news segment, we cover a new letter on contract pharmacy from Congress to the Department of Health and Human Services and new developments on Medicare payments for 340B drugs. The Relationship between Inventory Management and 340BMelissa explains why...2022-07-2515 min340B InsightA Specialty Pharmacy Case StudyMany 340B hospital professionals want to know how to operate an efficient specialty pharmacy that improves patient health outcomes. This week, we are joined by Betty Fang, director of ambulatory, specialty, and retail pharmacy at AdventHealth Great Lakes Region, formerly part of AMITA Health. Betty discusses how she helped lead a team that embedded specialty pharmacists into an oncology clinic. The team researched how the initiative improved patient health outcomes and increased 340B savings to reinvest in patient care. Before the interview, we provide several news updates on the contract pharmacy dispute and the release of 340B Health’s se...2022-07-1120 min340B InsightU.S. Supreme Court Decision on Medicare Cuts to 340BThe U.S. Supreme Court issued a major decision earlier this month regarding Medicare Part B cuts for 340B drugs. We’re joined by Amanda Nagrotsky, senior counsel for 340B Health to understand what implications this decision holds for 340B hospitals. This Decision was Years in the Making Amanda provides important background on the Medicare Part B cuts and the different court cases that led to the U.S. Supreme Court deciding the case. An Important Victory for 340B Hospitals Amanda discusses the unanimous court decision in favor of 340B hospitals, whether the decision coul...2022-06-2717 min340B InsightHow Data Analytics Support Your 340B ProgramThis week, we are joined by Bhupinder Kaur, business analyst and 340B coordinator with NorthBay Healthcare Group in California. Bhupinder presented at the 340B Coalition 2021 Winter Conference on data analysis and shares with us important information that 340B professionals need to know about best practices. Before the interview, we highlight a recently published op-ed on the critical role of 340B savings during the height of the COVID-19 pandemic.A Day in the Life of a 340B AnalystBhupinder shares her path to becoming a 340B analyst, the changing nature of her work...2022-06-0617 min340B InsightA 340B Update from the State LevelIt’s our 50th episode! This week we are joined by Amanda Sellers Smith, legal counsel for 340B Health. Amanda is responsible for tracking and responding to 340B state legislative and regulatory actions. Even though 340B is a federal program, its close relationship with state Medicaid programs often keeps it on the agendas of state lawmakers and health officials. Amanda discusses what listeners need to know about recent 340B activity in the states. Before the interview, we give an update on recent briefs to appeals courts that are considering cases about the contract pharmacy dispute, and we note that an...2022-05-2320 min340B InsightUsing 340B Savings to Tackle Health DisparitiesThis week, we are joined by Coletta Barrett, vice president of mission at Our Lady of the Lake Regional Medical Center. Our Lady of the Lake (OLOL) is using its 340B savings to pursue health equity initiatives. Coletta shares best practices and provides inspiration for how 340B professionals can work toward eliminating health disparities in their hospitals and communities. Before the interview, we share updates on a new 340B Health survey report demonstrating the harm to hospitals and patients of drug company restrictions on discounts for drugs dispensed at community and specialty contract pharmacies. H...2022-05-0922 min340B InsightHow You Can Advocate for 340B – and Why You ShouldThis week, we are joined by Laurie Chiumento, director of federal relations and healthcare policy at UR Medicine, the health system for the University of Rochester in New York. Laurie is an expert on how health systems and hospitals can advocate and promote their legislative priorities to members of Congress. She shares advice to hospitals that are preparing to speak with their elected officials about 340B issues or are considering doing so. She also discusses advocacy days in D.C., opportunities to host elected officials for visits to your hospital, and the 2022 midterm elections. Before the interview, we provide...2022-04-2519 min340B InsightCelebrating the 340B Ceiling Price Website’s SuccessThis week, we are joined by Steven Miller, vice president of pharmacy services at 340B Health. April 1 was the third anniversary of the federal 340B ceiling price website’s launch. Steve discusses how this database has become an invaluable tool for 340B drug pricing transparency. Before the interview, our news update shares how HRSA escalated enforcement actions against one of the companies restricting 340B discounts. The update also notes the release of 340B Health’s 2021 annual survey report on how hospitals are using their savings. How the Ceiling Price Website OperatesThe drug...2022-04-1118 min340B Insight340B Check-in with Maureen TestoniThis week, we are joined for the latest in our regular check-ins with 340B Health President and CEO Maureen Testoni. Maureen analyzes the top issues in 340B that occurred in the early months of 2022. These include updates on the 340B community pharmacy dispute and a new law that protects 340B eligibility for hospitals serving on the front lines of the COVID-19 pandemic. Drug Company 340B Restriction Trends There now are 16 companies restricting 340B discounts to safety-net hospitals on drugs dispensed at community pharmacies. Maureen shares updates and in-depth analysis on the three ma...2022-03-2922 min340B InsightHow to Build a Hospital’s 340B TeamThis week, we are joined by Paul Mollo, national director of medication outcomes disparity at Ascension. Paul discusses what skills and professional backgrounds hospitals consider when building a team to operate their 340B programs and ensure compliance. He also shares overall 340B staffing trends. Before the interview, our news update covers the appointment of a new HRSA Office of Pharmacy Affairs director. 340B Team Structure Paul explains how Ascension’s 340B team is structured at the national, regional, and local levels, as well as staffing models at other 340B hospitals. Under his lead...2022-03-1420 min340B Insight340B-Related Inquiries and Self-DisclosuresThis week, we are joined by Emily Cook, partner at McDermott Will & Emery LLP. At the 340B Coalition Winter Conference, Emily spoke on a new panel about the importance of 340B professionals understanding compliance issues related to 340B that are not covered by the 340B statute. We hear from her about that session, including the process for preparing for government inquiries and the need for hospitals to self-disclose government overpayments. Before the interview, we provide updates on multiple developments in the 340B contract pharmacy dispute.Working with the Legal and Compliance Department E...2022-02-2821 min340B InsightDrug Price Hikes Already Have Started for 2022This week, we are joined by Lauren Aronson, executive director for the Campaign for Sustainable Drug Pricing (CSRxP). CSRxP is a coalition of health care leaders, including providers, hospitals, patients, and health plans, that monitors drug pricing developments and promotes bipartisan solutions to lower U.S. drug prices. Lauren discusses recent alarming drug pricing trends, the role 340B plays in the drug pricing debate, and expectations for drug pricing legislation in 2022. Before the interview, we give an update on the 340B contract pharmacy dispute. Trends in Drug PricingCSRxP was formed in r...2022-02-1418 min
The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00The Unconstrained PodcastEP128 - Winning with rising interest ratesAs I record this, Goldman Sachs have stated that they expect the US Federal Reserve to raise interest rates 6 times this year. And many speculators are thinking the Fed will try and get to about a 2.5% base interest rate in order to try and reign in inflation. But although we had this only a couple of years ago, this could result in a lot of changes in the economical world that we all live in. In this episode I want to discuss different strategies that you can have to deal with rising interest rates in your own personal finances.2022-02-131h 00340B InsightOpening a 340B Hospital-Owned Specialty PharmacyThis week, we are joined by Leslie Pires, director of specialty pharmacy and 340B for Care New England Health System in Rhode Island. Leslie successfully helped start Care New England’s first specialty pharmacy. She shares what 340B hospitals need to know about opening a specialty pharmacy, how to gain accreditation, and how to remain compliant with 340B. Before the interview, we update our listeners on a 12th drug company that has imposed restrictions on 340B pricing for drugs dispensed at community pharmacies as well as a new bipartisan letter from Congress to HHS about the increasing number of dr...2022-01-3117 min340B Insight340B Addresses Social Determinants of Health for Patients with HIVThis week, we are joined by Dr. Ellen Eaton, an assistant professor and infectious disease specialist at the University of Alabama at Birmingham. Dr. Eaton works at UAB Medicine’s 1917 Clinic, a Ryan White HIV/AIDS clinic that relies on 340B savings to treat its patients. She discusses how the health system’s clinic has partnered with local community housing organizations to provide temporary housing support to patients with unstable housing to improve their medication adherence and overall health outcomes. Before the interview, we bring our listeners up to speed on a big update in the 340B community pharmacy disp...2022-01-1821 min340B InsightMaureen Testoni Analyzes the Latest Developments in 340BThis week, we are joined again by 340B Health President and CEO Maureen Testoni. Maureen discusses and analyzes major developments for the 340B program that occurred this fall. These include updates on the community pharmacy dispute, legislation on drug pricing, and the U.S. Supreme Court hearing arguments on Medicare pay cuts to 340B hospitals. Court Decisions in the 340B Community Pharmacy Dispute More drug companies in recent months have announced plans to restrict 340B pricing on drugs dispensed at community pharmacies. Maureen discusses that development, recaps multiple court decisions affecting the di...2021-12-1417 min340B InsightDiabetes Month and 340BNovember is American Diabetes Month. To explore how 340B supports care for patients living with diabetes, we speak with Salem Health’s Riley Protz, pharmacy inventory and 340B program manager, and AJ Sowles, manager of ambulatory care clinical pharmacy services. Riley and AJ discuss Salem Health’s use of 340B savings to create a medication management clinic that is helping improve the health outcomes of patients living with diabetes. Before the interview, we share exciting news about 340B Insight, recap several recent federal court decisions in the 340B community pharmacy dispute, and provide an update on Medicare payment cuts to 3...2021-11-1522 min340B InsightA Patient’s Perspective on 340BNov. 4, 2021, is the 29th anniversary of the 340B drug pricing program. To celebrate how 340B has benefited patients, we are joined by Jennifer Gallagher, lead pharmacy technician at Parkview Medical Center in Pueblo, Colo. Jennifer is not only a provider, she also is a patient whose health care journey has repeatedly intersected with the 340B program. She shares her story of how the 340B program has provided her access to the care she has needed to manage multiple health challenges. Before the interview, we answer a listener's question about HRSA audits of drug companies participating in 340B.2021-11-0120 min340B InsightResponding to the COVID-19 Delta VariantThis week, we are joined again by Scott Milner, senior director of pharmacy, business development, purchasing, 340B, and infusion services at St. Luke’s Health System in Idaho. We had spoken with Scott in January about the initial distribution of COVID-19 vaccines, and we reconnected with him to hear about how St. Luke’s has responded to a recent surge in COVID cases from the Delta variant and its effect on 340B program management.Redeploying Care for COVID-19 PatientsIt’s been more than 18 months since the COVID-19 pandemic began, and Scott discus...2021-10-2521 min340B Insight340B Child Site RegistrationThis week, we are joined by Amanda Nagrotsky, 340B Health’s legal counsel. Child sites are a key component of how hospitals reach more patients and provide more health care services. Amanda discusses what hospitals need to know about registering child sites, including eligibility requirements, registration timelines, required documents, and what resources are available to help them navigate the process.Before the interview, we give an update on HRSA taking an enforcement action against another drug company who has refused to provide 340B discounts when drugs are dispensed at community pharmacies. Eligibility Requirements for 340B C...2021-10-1220 min340B InsightHRSA Takes New Action Against Drug Companies Denying 340B DiscountsThis week, we are joined by Maureen Testoni, 340B Health’s president and CEO. The Health Resources & Services Administration (HRSA) made a major announcement recently regarding drug companies that are denying 340B discounts on drugs dispensed at community pharmacies. Maureen analyzes the news and discusses what comes next on this issue. She also catches us up on several other important 340B developments from during the summer. HRSA Refers Six Drug Companies for Possible Fines HRSA recently referred the first six drug manufacturers that imposed 340B pricing restrictions to the Health and Human Serv...2021-09-3024 min340B InsightTelehealth for 340B HospitalsThis week, we are joined by Sumona Das Gupta, assistant director of pharmacy audit and compliance at University of Washington Medical Center and Harborview Medical Center. As part of the UW Medicine health system, the hospitals operate in the first region of the U.S. that experienced community transmission of COVID-19 last year. Sumona discusses how her hospitals quickly expanded their telehealth capacity to serve patients, how this transformation impacted their 340B program operations and compliance, and the benefits telehealth brings to both patients and providers. Telehealth Before and During the COVID-19 Pandemic ...2021-09-1322 min340B InsightThe Hospital CFO’s Perspective on 340BThis week, we are joined by Tim Maurice, chief financial officer for UC Davis Health. Tim discusses how hospital finance teams support 340B and how they work together with hospital departments to provide the resources for health care services that patients need. Prior to the interview, we share a news update on an eighth drug manufacturer that plans to deny 340B discounts on drugs dispensed at community pharmacies. How Health System Finances Have Changed Over the YearsHealth system finances have drastically changed over the years. Tim shares how UC Davis has r...2021-08-3020 min340B InsightPharmacy Technicians and 340BThis week, we are joined by Nan Kempadoo, 340B internal auditor for Memorial Healthcare System in Hollywood, Fla. Nan is a certified pharmacy technician who spoke on the pharmacy technician roundtable at last month’s 340B Coalition Summer Conference. She discusses how pharmacy techs play an important role in the operations and compliance of 340B hospitals and notes the growing number of career opportunities available to them in 340B. Before the interview, we give an update on a seventh drug company that has refused 340B discounts to safety-net providers when drugs are dispensed at community pharmacies as well as ho...2021-08-1619 min340B InsightPreparing For 340B RecertificationThis week, we are joined by Steven Miller, vice president of pharmacy services at 340B Health. The Health Resources & Services Administration (HRSA) recently announced that annual 340B recertification for hospitals will begin on Aug. 16, 2021. Steve discusses what 340B hospitals need to know about preparing for recertification and avoiding common errors during the process. Prior to the interview, we provide news updates on the Centers for Medicare & Medicaid Services proposing to continue Medicare Part B cuts to many 340B hospitals and new legislation introduced in Congress to protect 340B hospitals from discriminatory payment rules by pharmacy benefit managers and health...2021-07-2621 min340B InsightMeeting with Policymakers to Protect 340BThis week, we are joined by Bryan Jackson, chief administrative officer at Jefferson Regional Medical Center in Arkansas. Bryan discusses why he advocates for 340B at the federal and state levels, explains how to prepare for and participate in advocacy meetings with policymakers and their staff, and shares his advocacy success stories. Prior to the interview, our news segment discusses how a seventh drug company is threatening to start denying 340B discounts on drugs dispensed at community pharmacies and how the U.S. Supreme Court will be hearing a 340B-related case during its next term. 2021-07-1221 min340B InsightUpdates on the 340B Contract Pharmacy Dispute with Maureen TestoniThis week, we are joined by 340B Health President and CEO Maureen Testoni. Maureen provides analysis of the most recent developments regarding the 340B contract pharmacy dispute and what’s next in the efforts to resolve the matter. Before our conversation, we share the findings of a recently released 340B Health report that demonstrates how 340B hospitals are treating large percentages of patients who often are underserved by the broader health care system.HRSA’s Letters to Drug CompaniesOn May 17, HRSA sent letters to the six drug companies that have refused to p...2021-06-2819 min340B InsightAddressing Payer-Mandated White Bagging of DrugsThis week, we are joined by Kyle Robb, a state policy and advocacy associate for the American Society of Health System Pharmacists (ASHP). Kyle discusses the rise in payer-mandated white bagging, why hospital pharmacists are concerned about the trend, and how health providers and patients are affected by this model. Before the interview, our news update covers the critical step the Health Resources & Services Administration (HRSA) recently took to enforce the law on drug companies that have refused discounts to 340B covered entities when drugs are dispensed at contract pharmacies.The Differences Between White...2021-06-0721 min340B InsightDrug Company 340B Discount Refusals Harm PatientsIt is the one-year anniversary of 340B Insight, and this week we are joined by Anne Webster, a nurse practitioner for UnityPoint Health Methodist in Peoria, Ill. Anne discusses how drug company restrictions on 340B pricing on drugs dispensed at community pharmacies have directly affected her patients living with diabetes and their ability to access the insulin and other medications they need to manage their conditions. Please note that the episode was recorded prior to the Health Resources & Services Administration (HRSA) announcing on May 17, 2021, that drug companies refusing 340B discounts to safety-net hospitals and providers on drugs dispensed at...2021-05-1720 min340B InsightHow 340B Fits Into the Drug Pricing WorldThis week we are joined by Sean Dickson, director of health policy for West Health Policy Center. Sean is an expert on the U.S drug system and focuses on policies that reduce prescription drug costs. Sean discusses why drug prices are so high, his research on how 340B fits into the drug pricing policy conversation and affects overall drug pricing, and what approaches policymakers can take to curb high drug prices. Before the interview, our news update shares developments on drug pricing bills recently introduced in Congress and how a group of hospital and pharmacy organizations, including 340B...2021-05-0321 min340B InsightMaureen Testoni on Top 340B DevelopmentsThis week we are joined by Maureen Testoni, 340B Health’s president and CEO. Maureen provides her expert analysis on the top 340B developments from the first quarter of 2021. The conversation includes the latest on drug manufacturers denying 340B discounts on drugs dispensed at community pharmacies, attempts to turn 340B into a rebate program, and payers and pharmacy benefit managers making mandatory changes to their claims processes. Maureen also shares positive recent developments on advocating for 340B. Updates on the Community Pharmacy IssueThe Department of Health and Human Services (HHS) has ind...2021-04-1923 min340B Insight340B in the World of Cancer TreatmentApril is National Cancer Control Month, and this week we are joined by Dr. Gerold Bepler, president and CEO at the Barbara Ann Karmanos Cancer Institute in Detroit. Dr. Bepler discusses the unique role cancer centers play in preventing and treating cancer, the importance of 340B to Karmanos and its patients, how Karmanos is addressing racial and ethnic disparities in cancer treatment, and the partnership it has formed to expand access to cancer research and treatment in rural communities. Before the interview, we recap 340B Health’s recent virtual Hill Day. The Karmanos Comprehensive App...2021-04-0521 min340B InsightHow State Policy Affects 340BThis week we are joined by Amanda Sellers Smith, the assistant counsel for 340B Health. While 340B is a federal program, it is intertwined with Medicaid and states’ oversight of the health care marketplace. Amanda discusses how states are protecting 340B covered entities from discriminatory reimbursement, why changes to state Medicaid policy can affect 340B in multiple ways, and how listeners can advocate for 340B at the state level. Before the interview with Amanda, we recap the results of the newly released 340B Health annual survey of 340B hospitals. How States Can Protect 340B Hos...2021-03-2220 min340B InsightRyan White Clinics and Their Importance to the 340B CommunityThis week we are joined by Dr. John Carlo, CEO of Prism Health North Texas. Prism Health is a Ryan White Clinic, which are grantees of the Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS program. They provide care to patients at risk of or living with HIV/AIDS and are one of 16 types of 340B covered entities. John discusses 340B’s role in Prism Health’s ability to care for patients, how Ryan White Clinics work together with 340B hospitals, how they are serving patients during the pandemic, and the latest innovations in HIV care. Before the...2021-03-0821 min340B InsightPursuing Health Equity: Part TwoThis week we continue our two-part series focused on how 340B hospitals are pursuing health equity. In our recently released Health Equity Report, 340B Health profiled nine hospitals working to eliminate health disparities in their communities. Today, we continue sharing the stories of three hospitals from that report. For this episode, we are broadcasting from our virtual booth in the exhibit hall at the 340B Coalition Winter Conference that started Feb. 16 and will run through Feb. 24. After we recorded this episode, a federal judge granted the government’s motion to dismiss a joint lawsuit tha...2021-02-2218 min340B InsightPursuing Health EquityThis week, we begin a two-part series focused on how 340B hospitals are pursuing health equity. The COVID-19 pandemic has spotlighted the significant racial and ethnic disparities in health care and patient health outcomes. Today, we focus on three hospitals featured in 340B Health’s recently released health equity report and hear more about how they’re working to eliminate health disparities in their communities. Before we launch into the episode, we answer a member question about the many lawsuits that have been filed related to disputes over 340B contract pharmacies. We sit down with...2021-02-1018 min340B Insight340B Hospitals Are COVID Vaccine LeadersThis week we are joined by Scott Milner, senior director of pharmacy, business development, purchasing, 340B, and infusion services at St. Luke’s Health System in Idaho. Scott shares his personal experiences on how the health system has been finding ways to overcome COVID-19 vaccine distribution challenges and describes how the effort has become a personal mission for him. Prior to the interview, we discuss in our news update segment how drug companies are suing HHS in response to the department’s advisory opinion on 340B contract pharmacies. When we recorded the episode, three companies had filed such lawsuits. Sinc...2021-01-2523 min340B InsightPreparing for HRSA Audits This week we are joined by Steven Miller, vice president of pharmacy services at 340B Health. Steve discusses Health Resources & Services Administration (HRSA) audits of 340B hospitals and shares practical advice for how hospitals can best prepare, including the resources that are available to them. Prior to the interview, we provide a major news update you might have missed during the holiday season on the ongoing 340B contract pharmacy issue. HRSA Audits 101In 2015, HRSA started auditing 200 covered entities each fiscal year, with 155 of those covered entities being 340B hospitals. HRSA uses an al...2021-01-1121 min340B InsightMaureen Testoni Recaps 340B for 2020In our final episode of 2020, we are joined by Maureen Testoni, the president and CEO of 340B Health. Our episode follows up last week’s bonus episode on 340B Health’s recent joint lawsuit against the Department of Health and Human Services regarding drug manufacturers’ refusals to provide 340B discounts when drugs are dispensed at community-based contract pharmacies. Maureen provides additional analysis on the issue and discusses her concerns with how some drug companies are attempting to change 340B into a rebate program. She also discusses the role 340B has played in helping hospitals respond to the COVID-19 pandemic this y...2020-12-2117 min340B InsightBONUS EPISODE: Taking the 340B Case to CourtThis week we have a breaking news bonus episode of 340B Insight. 340B Health President and CEO Maureen Testoni joins us to discuss the filing of a lawsuit against the Department of Health & Human Services with four other national hospital organizations, a national pharmacist’s organization, and three individual 340B hospitals, seeking to halt drug companies’ refusals to provide 340B discounts to hospitals on covered drugs dispensed at community-based contract pharmacies. Manufacturers’ Actions are Unlawful A group of major drug companies have taken unilateral actions to refuse to provide 340B pricing, and the federal government has fail...2020-12-1608 min340B InsightResponding to COVID-19’s ResurgenceThis week we are joined by Danielle Sestito, system director for the 340B program at Northwell Health in New York. Northwell Health is New York’s largest health system and was one of the systems most affected by the initial COVID-19 outbreak last spring. Danielle shares how Northwell responded to the initial outbreak and how it has prepared for a resurgence. She also discusses how the health system has avoided drug shortages while maintaining 340B compliance and the importance of HRSA’s 340B regulatory flexibilities during the public health emergency. Prior to the interview, we share updates on how some...2020-12-0721 min340B InsightThe Biden Administration, New Congress, and 340BThis week, we speak with Rodney Whitlock, former legislative staffer for Republicans on Capitol Hill and Jeremy Sharp, a former Capitol Hill and executive branch staffer for Democrats. Rodney and Jeremy discuss with 340B Health’s Kathryn DiBitetto how the incoming Biden administration and new Congress might affect the 340B program. The conversation also discusses what the congressional lame-duck session before the end of the year will mean for 340B and how hospital advocates should be preparing for the new administration and new Congress. Prior to the interview, we share news updates, including a bipartisan House of Representatives letter to...2020-11-2322 min
The Earnings Podcast from AlphaStreetVirgin Galactic Holdings, Inc. (SPCE) Q3 2020 Earnings CallVirgin Galactic Holdings, Inc. (NYSE: SPCE) Q3 2020 earnings call dated Nov. 05, 2020
Corporate Participants:
Michael A. Colglazier — Chief Executive Officer
Michael P. Moses — President, Space Missions and Safety
Jonathan Campagna — Chief Financial Officer
Analysts:
Adam Jonas — Morgan Stanley — Analyst
Robert Spingarn — Credit Suisse — Analyst
Myles Walton — UBS — Analyst
Ronald Epstein — Bank of America Merrill Lynch — Analyst
Oliver Chen — Cowen and Company — Analyst
Noah Poponak — Goldman Sachs — Analyst
Pete Skibitski — Alembic Global Advisors — Analyst
---
Send in a voice message: https://podcasters.spotify.com/pod...2020-11-0950 min340B InsightCelebrating National Rural Health DayFor this episode of 340B Insight we speak with Alan Morgan, CEO of the National Rural Health Association. Alan previews National Rural Health Day on November 19, discusses how rural hospitals are faring during the COVID-19 pandemic, the future of rural hospitals, the role of 340B to help hospitals stay afloat, and why drug manufacturers attacks on contract pharmacies are detrimental to rural hospitals and their patients. In our news segment prior to the interview, we recap how Novartis has become the fourth drug manufacturer to block 340B discounts when drugs are dispensed at some contract pharmacies. We also celebrate...2020-11-0923 min
The Earnings Podcast from AlphaStreetJetBlue Airways (JBLU) Q3 2020 Earnings Results CallJBLU Earnings: All you need to know about JetBlue Airways Q3 2020 earnings results
October 27, 2020
JetBlue Airways Corporation (NASDAQ: JBLU) reported third quarter 2020 earnings results today. Total operating revenues declined 76% year-over-year to $492 million. The company reported a net loss of $393 million, or $1.44 per share, compared to net income of $187 million, or $0.63 per share, last year. Adjusted loss per share amounted to $1.75. The results were better than market expectations.
Corporate Participants:
David Fintzen — Vice President, Investor Relations
Robin Hayes — Chief Executive Officer
Joanna Geraghty — President and Chief Operat...2020-10-271h 02The Earnings Podcast from AlphaStreetAlaska Air Group Inc (ALK) Q3 2020 Earnings CallAlaska Air Group is a Washington-based company which operates the low-cost carrier Alaska Airlines, which has hubs in Seattle, San Francisco, Los Angeles and Oregon, along with Horizon Air. The company has a market cap of $4.63 billion.
Corporate Participants:
Emily Halverson — Director, Investor Relations
Brad Tilden — Chairman and Chief Executive Officer
Ben Minicucci — President of Alaska Airlines
Shane Tackett — Executive Vice President Finance and Chief Financial Officer of Alaska Air Group
Andrew Harrison — Executive Vice President and Chief Commercial Officer of Alaska Airlines
Nathaniel Pieper — Senior Vice President of...2020-10-261h 02340B InsightAdvocacy in ActionIn this episode, we speak with Julie Clements, Director of Health and Clinical Affairs at the University of California Office of Federal Government Relations. Clements details why advocating for 340B is critical, how health care professionals can engage in advocacy, and how advocacy has changed during the COVID-19 pandemic.The Importance of Health Care Professionals Advocating For 340B: Clements discusses how important it is for those who work with the 340B program every day, such as pharmacists and other health care professionals, to provide their first-hand experiences to policymakers on how beneficial 340B is t...2020-10-2622 min
The Earnings Podcast from AlphaStreetLockheed Martin Corp. (LMT) Q3 2020 Earnings CallLockheed Martin Corp. (NYSE: LMT) Q3 2020 earnings call dated Oct. 20, 2020
Transcript: Click here
Infographic: Click here
Aerospace company Lockheed Martin (NYSE: LMT) Tuesday said its sales increased 9% in the third quarter, driving up net profit. The top-line also came in above the market’s prediction. The stock made modest gains soon after the announcement. In a sign that the virus-related disruption did not affect orders materially, net sales rose 8.6% from last year to $16.5 billion in the September-quarter. It is above the consensus estimate. In the most recent quarter, earnings rose to $1.7 billion or $6.05 pe...2020-10-211h 02340B InsightResearching 340B’s Value to Medication Therapy ManagementIn this episode, we spoke with Dr. Jessica Tilton, the clinical coordinator for the University of Illinois Health Medication Therapy Management Clinic and a clinical assistant professor in the Department of Pharmacy Practice at the University of Illinois at Chicago College of Pharmacy. Jessica discusses the research she and her colleagues have conducted that demonstrates how the clinic is measurably improving patient health outcomes. Prior to the interview, we provide news updates on additional drug manufacturers refusing to provide 340B discounts and the Centers for Medicare and Medicaid Services reviewing comment letters regarding its proposals to make deep Medicare...2020-10-1319 min340B InsightA Guide to 340B ResearchIn this episode, we speak with Caroline Steinberg, Vice President of Research and Policy Analytics at 340B Health, about research into the 340B program. For more information about 340B Health’s research, you can review the research page on our website. Before the interview, our news segment covers the latest updates on proposed Medicare cuts to 340B hospitals and 340B Health’s Virtual Hill Day last week. The Role of Research: Research is vital for educating policymakers about the 340B program to help ensure continuing support for the program. Research also helps demonstrate that the program is vita...2020-09-2920 min340B Insight340B and Caring for People Experiencing HomelessnessIn this episode, we spoke with Nicole Shoquist, Chief Pharmacy Officer for JPS Health Network in Fort Worth, Texas. Nicole described the importance of 340B in meeting the needs of patients experiencing homelessness. Nicole describes JPS’s innovative response to care for these patients during the height of the pandemic that included telehealth and new ways to help patients receive their prescriptions. Prior to the interview, our news update segment provides an update on drug manufacturers refusing to offer 340B pricing when drugs are dispensed at community pharmacies. 340B Savings Stretch Scarce Resources: Prior to...2020-09-1420 min340B InsightAnalyzing 340B News from the Courts to Pharma Manufacturer ActionsIn this episode we speak with Maureen Testoni, President and CEO for 340B Health, on new 340B policy developments in recent weeks that include a major court decision and drug manufacturer challenges to 340B contract pharmacies. Prior to the interview, we answer a member question on changes this year to the 340B hospital recertification process. Some key takeaways from the conversation with Testoni include:Court Decision Upholds CMS Medicare Part B Cuts: Since 2018, The Centers for Medicare & Medicaid Services (CMS) has cut payments by nearly 30% to many 340B hospitals. T...2020-08-1718 min340B InsightAddressing Healthcare Disparities During the COVID-19 PandemicIn this episode, we spoke with Dr. Jewel Younge, Clinical Pharmacist at the University of Illinois Hospital & Health Sciences System (UI Health) and Clinical Assistant Professor at the University of Illinois Chicago College of Pharmacy. We invited Jewel on the podcast after she participated in a panel discussion on health care inequalities during the 340B Coalition Virtual Summer Conference in late July. At the start of the episode, we discussed several news updates including a new presidential executive order regarding the 340B program. Some key takeaways from the conversation with Jewel Younge include:2020-08-0322 min340B Insight340B Helps Hospitals Meet Patients Where They AreIn this episode, we speak with Sarah Dodson, the 340B Program Director at Ascension Via Christi, the largest health care provider in Kansas. Sarah talks about her work with the Community Cares Clinic, which provides comprehensive and hands-on care for vulnerable patients. It’s also been a busy news month for 340B. In our news update segment, we discuss a drug manufacturer’s unprecedented new policy for refusing 340B pricing on one of its drugs to a covered entity that will be distributing that drug through a contract pharmacy. We also discuss new, bipartisan pro-340B legi...2020-07-2020 min340B Insight340B’s Role in Supporting Rural Health CareIn this episode of 340B Insight we speak with Chuck Beams, executive director of pharmacy services, business development, and government relations at East Alabama Medical Center (EAMC), about how the 340B program helps EAMC serve its rural community. We also provide 340B news updates regarding the CMS Medicare Part B cuts to 340B hospitals and new 340B research. A Diverse Patient Population: EAMC is located in Opelika, Alabama, and serves 11 counties, totaling a population of nearly half a million. Although it is located near Auburn University, it serves many underserved, rural patients who live in nearby c...2020-07-0622 min340B InsightHow 340B Helped a Rural Hospital Care for COVID-19 PatientsIn this episode, we speak with Tracy Gilmore, 340B specialist at Labette Health in Parsons, Kansas. Tracy discusses her hospital’s experience responding to COVID-19 in a rural community and highlights the lifesaving impact of 340B on Labette Health and its patients.A Strong Hospital for the Local Community: Labette County faces numerous challenges, including high poverty rates and childhood hunger. Amid these challenges, Labette Health is a staple of the community providing excellent service for Labette and patients from neighboring counties.Robust Response and Sacrifices During COVID-19: Labette He...2020-06-1520 min340B InsightLessons Learned from the Earliest Days of COVID-19In this episode, we speak with Mike Bonck, Manager of Pharmaceutical Services for CHI Franciscan Health (CHIFH) in Tacoma, Washington, about the impact of COVID-19 on the US health care system. CHIFH is a system with four DSH hospitals, one rural referral center, and one critical access hospital that participate in the 340B program. Tacoma is one of the most significantly affected regions of the U.S., having experienced a major surge of COVID-19 cases in March and April. CHIFH was one of the first hospital systems in the U.S. to face the e...2020-06-0120 min340B InsightThe State of 340B During COVID-19 with Maureen TestoniIn this episode, we speak with our President and CEO, Maureen Testoni, about the impact of COVID-19 on the 340B program. Maureen has been leading 340B Health since April 2018 and previously served as the Senior Vice President and General Counsel for the organization.Maureen discusses several key issues for the 340B community amid the uncertainty of the COVID-19 pandemic. Some key discussion topics include: 1.HRSA’s Response to COVID-19: HRSA has provided flexibility for hospitals on 340B drug purchases, registration of new hospital clinics, and telemedicine. However, there are additional steps HRSA should take...2020-05-2117 min340B InsightHRSA’s OPA Response to COVID-19 with Rear Admiral Krista Pedley340B Insight is a podcast hosted by 340B Health that provides its members and supporters with timely news updates and discussion around the 340B drug pricing program. This inaugural episode includes news updates on the Centers for Medicare and Medicaid Services going ahead with a controversial survey of 340B hospitals, and lawmakers on Capitol Hill asking congressional leaders to protect 340B during the COVID-19 pandemic. In the feature interview for this episode, the President and CEO of 340B Health, Maureen Testoni, speaks with Rear Admiral Krista M. Pedley, the Director of the Offi...2020-05-1822 min340B InsightIntroducing the 340B Insight PodcastWelcome to 340B Insight! Hosted by 340B Health, the nation’s leading advocate for hospitals participating in the 340B drug pricing program. 340B Insight features the latest news, expert interviews, and answers to your questions. Learn about the ways 340B hospitals use program savings, demonstrate patient health improvements, respond to public health emergencies, and more.2020-05-0403 min
Jags Den PodcastJags Den Podcast Ep. 50: Discussions on Jags' 53-man depth chart, Jack's extension and Chiefs Wire crossoverJags Wire's James Johnson and Jacob DeLawrence start the regular season off with a bang, discussing all of the marquee Jags news of Week 1 as Myles Jack got an extension and the Jags set their 53-man roster. Also, the crew had in Charles Goldman of the Chiefs Wire to get some intel on Patrick Mahomes and company.2019-09-061h 26
Jags Den PodcastJags Den Podcast Ep. 50: Discussions on Jags' 53-man depth chart, Jack's extension and Chiefs Wire crossoverJags Wire's James Johnson and Jacob DeLawrence start the regular season off with a bang, discussing all of the marquee Jags news of Week 1 as Myles Jack got an extension and the Jags set their 53-man roster. Also, the crew had in Charles Goldman of the Chiefs Wire to get some intel on Patrick Mahomes and company.2019-09-061h 28